Compare HALO & ORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HALO | ORA |
|---|---|---|
| Founded | 1998 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 6.9B |
| IPO Year | N/A | 2004 |
| Metric | HALO | ORA |
|---|---|---|
| Price | $68.77 | $112.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | $73.33 | ★ $117.13 |
| AVG Volume (30 Days) | ★ 2.3M | 581.4K |
| Earning Date | 11-03-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 0.42% |
| EPS Growth | ★ 56.68 | 11.26 |
| EPS | ★ 4.74 | 2.18 |
| Revenue | ★ $1,242,852,000.00 | $944,248,000.00 |
| Revenue This Year | $34.83 | $11.57 |
| Revenue Next Year | $24.84 | $17.28 |
| P/E Ratio | ★ $14.54 | $51.83 |
| Revenue Growth | ★ 31.19 | 6.07 |
| 52 Week Low | $47.00 | $61.58 |
| 52 Week High | $79.50 | $116.66 |
| Indicator | HALO | ORA |
|---|---|---|
| Relative Strength Index (RSI) | 58.75 | 53.33 |
| Support Level | $61.23 | $110.26 |
| Resistance Level | $69.28 | $115.39 |
| Average True Range (ATR) | 1.69 | 2.70 |
| MACD | 0.69 | -0.04 |
| Stochastic Oscillator | 93.54 | 56.95 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: Electricity Segment. where the company develops, builds, owns and operates geothermal, solar PV and recovered energy-based power plants in the United States and geothermal power plants in other countries and sell the electricity generated. Product Segment includes designing, manufacturing and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement and construction of geothermal and recovered energy-based power plants. Energy Storage Segment includes owning and operating grid-connected which provide capacity, energy and ancillary services directly to the electric grid.